Last reviewed · How we verify
Small cell carcinoma of lung
Approved treatments
- Vepesid · Bristol-Myers Squibb K.K.
- Imfinzi · AstraZeneca
Imfinzi works by blocking the PD-L1 protein, allowing the immune system to recognize and attack cancer cells. - Nogitecan · Novartis
Topotecan is a topoisomerase inhibitor that prevents DNA re-ligation, causing double-strand DNA damage. - adriacin · Chipscreen Biosciences, Ltd.
- Hydroxydaunorubicin · University of Colorado, Denver
- Hycamtin · North Eastern German Society of Gynaecological Oncology
- Imfinzi · University Medical Center Groningen
- Zepzelca · Jazz Pharmaceuticals
Zepzelca works by attaching an alkyl group to DNA, which interferes with DNA replication and causes cell death. - Liposomal Doxorubicin · Pfizer
- Doxorubicin Hydrochloride · Pfizer
Doxorubicin works by intercalating DNA strands and inhibiting topoisomerase II, an enzyme essential for DNA replication and cell division. - Hydroxydaunomycin · Weill Medical College of Cornell University
- Adriamycin · Johann Wolfgang Goethe University Hospital
- Etoposid · University of Ulm
- Zepzelca · Jazz Pharmaceuticals
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Small cell carcinoma of lung patent landscape — cliff calendar, originator estates, attackable patents
- Small cell carcinoma of lung treatment landscape brief
- Small cell carcinoma of lung treatment updates RSS
Frequently asked questions about Small cell carcinoma of lung
What drugs treat Small cell carcinoma of lung?
Tracked treatments include Vepesid, Imfinzi, Nogitecan, adriacin, Hydroxydaunorubicin, Hycamtin, Zepzelca, Liposomal Doxorubicin.
What is the treatment for Small cell carcinoma of lung?
Standard treatment for Small cell carcinoma of lung includes Vepesid, Imfinzi, Nogitecan, adriacin, Hydroxydaunorubicin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Small cell carcinoma of lung patent cliff · Small cell carcinoma of lung CI report
- Treatment: Vepesid · Bristol-Myers Squibb K.K.
- Treatment: Imfinzi · AstraZeneca
- Treatment: Nogitecan · Novartis
- Treatment: adriacin · Chipscreen Biosciences, Ltd.
- Treatment: Hydroxydaunorubicin · University of Colorado, Denver
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing